Tuberculosis comorbidity with communicable and non-communicable diseases: Integrating health services and control efforts

The Lancet Infectious Diseases

Volumn 13, Issue 5, 2013, Pages 436-448

  Marais, Ben J ^a   Lönnroth, Knut ^b   Lawn, Stephen D ^c,d   Migliori, Giovanni Battista ^e   Mwaba, Peter ^f,g   Glaziou, Philippe ^b   Bates, Matthew ^f,q   Colagiuri, Ruth ⁱ   Zijenah, Lynn ^h   Swaminathan, Soumya ^j   Memish, Ziad A ^k,l   Pletschette, Michel ^m   Hoelscher, Michael ⁿ   Abubakar, Ibrahim ^p,q   Hasan, Rumina ^o   Zafar, Afia ^o   Pantaleo, Guiseppe ^r   Craig, Gill ^s   Kim, Peter ^t   Maeurer, Markus ^u   Schito, Marco ^t   Zumla, Alimuddin ^f,q   more..

^a UNIVERSITY OF SYDNEY   (Australia)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e IRCCS   (Italy)

^f UNIVERSITY OF ZAMBIA   (Zambia)

^g MINISTRY OF HEALTH   (Zambia)

^h UNIVERSITY OF ZIMBABWE   (Zimbabwe)

ⁱ UNIVERSITY OF SYDNEY   (Australia)

^j NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^k MINISTRY OF HEALTH   (Saudi Arabia)

^l ALFAISAL UNIVERSITY   (Saudi Arabia)

^m UNIVERSITY OF ZURICH   (Switzerland)

ⁿ LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^o AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

^p PUBLIC HEALTH ENGLAND   (United Kingdom)

^q UNIVERSITY COLLEGE LONDON   (United Kingdom)

^r LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^s CITY UNIVERSITY   (United Kingdom)

^t NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^u KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LOPINAVIR; PNEUMOCOCCUS VACCINE; PROTEINASE INHIBITOR; RIFABUTIN; RIFAMPICIN; RITONAVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALCOHOL CONSUMPTION; ALCOHOLISM; CD4 LYMPHOCYTE COUNT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNICABLE DISEASE; COMORBIDITY; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FINANCIAL MANAGEMENT; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; INFECTION CONTROL; LUNG CANCER; LUNG TUBERCULOSIS; MALNUTRITION; PRIORITY JOURNAL; REVIEW; SEXUALLY TRANSMITTED DISEASE; SMOKING; SMOKING CESSATION; SOCIOECONOMICS; TUBERCULOSIS; VERTICAL TRANSMISSION; VIRUS HEPATITIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; COINFECTION; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; COMORBIDITY; DIABETES MELLITUS; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MYCOBACTERIUM TUBERCULOSIS; NATIONAL HEALTH PROGRAMS; RISK FACTORS; SOCIOECONOMIC FACTORS; TUBERCULOSIS; WORLD HEALTH;

EID: 84876717473     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(13)70015-X     Document Type: Review

References (128)

1. Resolution adopted by the General Assembly: 66/2-political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases United Nations General Assembly, (accessed Feb 5, 2013). http://www.who.int/nmh/events/un_ncd_summit2011/political_declaration_en.pdf.
2. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2013, 380:2224-2260.
3. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2013, 380:2095-2128.
4. Murray CJL, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2013, 380:2197-2223.
5. Adeyi O, Smith O, Robles S Public policy and the challenge of chronic noncommunicable diseases (accessed Jan 16, 2013). http://siteresources.worldbank.org/INTPH/Resources/PublicPolicyandNCDsWorldBank2007FullReport.pdf.
6. Whiting DR, Guariguata L, Weil C, Shaw J IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011, 94:311-321.
7. Boutayeb A The double burden of communicable and non-communicable diseases in developing countries. Trans R Soc Trop Med Hyg 2006, 100:191-199.
8. Bygbjerg IC Double burden of noncommunicable and infectious diseases in developing countries. Science 2012, 337:1499-1501.
9. Remais JV, Zeng G, Li G, Tian L, Engelgau MM Convergence of non-communicable and infectious diseases in low- and middle-income countries. Int J Epidemiol 2012, published online Oct 13. 10.1093/ije/dys135.
10. Morens DM, Folkers GK, Fauci AS Emerging infections: a perpetual challenge. Lancet Infect Dis 2008, 8:710-719.
11. MacPherson DW, Gushulak BD, Baine WB, et al. Population mobility, globalization, and antimicrobial drug resistance. Emerg Infect Dis 2009, 15:1727-1732.
12. Masoud D, de Colombani P, Petrova-Benedict R, et al. Minimum package for cross-border TB control and care in the WHO European region: a Wolfheze consensus statement. Eur Respir J 2012, 40:1081-1090.
13. Blumberg HR, Migliori GB, Ponomarenko O, Heldal E Tuberculosis on the move. Lancet 2010, 375:2127-2129.
14. Zumla A, Abubakar I, Raviglione M, et al. Drug resistant TB: current dilemmas, unanswered questions, challenges and priority needs. J Infect Dis 2012, 205:S228-S240.
15. Keshavjee S, Farmer PE Tuberculosis, drug resistance and the history of modern medicine. N Engl J Med 2012, 36:931-936.
16. Global tuberculosis report 2012 WHO, (accessed Feb 5, 2013). http://www.who.int/tb/publications/global_report/en/index.html.
17. Surveillance report: tuberculosis surveillance and monitoring in Europe 2012 European Centre for Disease Surveillance and Control, WHO Regional Office for EuropeWHO Regional Office for Europe, (accessed Nov 20, 2012). http://ecdc.europa.eu/en/publications/Publications/1203-Annual-TB-Report.pdf.
18. Stuckler D, Basu S, McKee M Drivers of inequality in Millennium Developmental Goal progress: a statistical analysis. PLoS Med 2010, 7:e1000241.
19. Ploubidis GB, Palmer MJ, Blackmore C, et al. Social determinants of tuberculosis in Europe: a prospective ecological study. Eur Resp J 2012, 40:925-930.
20. Lönnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med 2009, 68:2240-2246.
21. Interim policy on collaborative TB/HIV activities WHO, (accessed Feb 5, 2013). http://whqlibdoc.who.int/hq/2004/WHO_HTM_TB_2004.330_eng.pdf.
22. WHO policy on collaborative TB/HIV activities: guidelines for national programmes and stakeholders WHO, (accessed Feb 5, 2013). http://whqlibdoc.who.int/publications/2012/9789241503006_eng.pdf.
23. Perez-Velez CM, Marais BJ Tuberculosis in children. N Engl J Med 2012, 367:348-361.
24. Chintu C, Mudenda V, Lucas S, et al. Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study. Lancet 2002, 360:985-990. for the UNZA-UCLMS Project Paediatric Post-mortem Study Group.
25. Guidance for national tuberculosis and HIV programmes on the management of tuberculosis in HIV-infected children: recommendations for a public health approach International Union Against Tuberculosis and Lung Disease, WHOWHO, (accessed Jan 16, 2013). http://sun025.sun.ac.za/portal/page/portal/South_to_South/uploads/TBHIVchildfinaldoc_12_03_10.pdf.
26. Getahun H, Sculier D, Sismanidis C, Grzemska M, Raviglione M Prevention, diagnosis, and treatment of tuberculosis in children and mothers: evidence for action for maternal, neonatal, and child health services. J Infect Dis 2012, 205:S216-S227.
27. Violari A, Cotton MF, Gibb DM, et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med 2008, 359:2233-2244.
28. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents AIDS Info, (accessed Jan 6, 2013). http://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-arv-guidelines/0/.
29. Abdool Karim SS, Naidoo K, Grobler A, et al. Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med 2011, 365:1492-1501.
30. Havlir DV, Kendall MA, Ive P, et al. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med 2011, 365:1482-1491.
31. Blanc FX, Sok T, Laureillard D, et al. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med 2011, 365:1471-1481.
32. WHO policy on collaborative TB/HIV activities: guidelines for national programmes and other stakeholders WHO, (accessed March 25, 2012). http://whqlibdoc.who.int/publications/2012/9789241503006_eng.pdf.
33. Suthar AB, Lawn SD, del Amo J, et al. Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis. PLoS Med 2012, 9:e1001270.
34. Levitt NS, Steyn K, Dave J, Bradshaw D Chronic noncommunicable diseases and HIV-AIDS on a collision course: relevance for health care delivery, particularly in low-resource settings: insights from South Africa. Am J Clin Nutr 2011, 94:1690S-1696S.
35. Dooley KE, Chaisson R Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis 2009, 9:737-746.
36. Harries AD, Lin Y, Satyanarayana S, et al. The looming epidemic of diabetes-associated tuberculosis: learning lessons from HIV-associated tuberculosis. Int J Tuberc Lung Dis 2011, 15:1436-1444.
37. Jeon CY, Murray MB Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 2008, 5:e152.
38. Stevenson CR, Forouhi NG, Roglic G, et al. Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence. BMC Public Health 2007, 7:234.
39. Viswanathan V, Aravindalochanan SV, Rajan R, et al. Prevalence of diabetes and pre-diabetes and associated risk factors among tuberculosis patients in India. PLoS One 2012, 7:e41367.
40. Lin Y, Li L, Mi F, et al. Screening patients with diabetes mellitus for tuberculosis in China. Trop Med Int Health 2012, 17:1302-1308.
41. Li L, Lin Y, Mi F, et al. Screening of patients with tuberculosis for diabetes mellitus in China. Trop Med Int Health 2012, 17:1294-1301.
42. Young F, Critchley JA, Johnstone LK, Unwin NC A review of co-morbidity between infectious and chronic disease in sub-Saharan Africa: TB and diabetes mellitus, HIV and metabolic syndrome, and the impact of globalization. Glob Health 2009, 5:9.
43. Dalal S, Beunza JJ, Volmink J, et al. Non-communicable diseases in sub-Saharan Africa: what we know now. Int J Epidemiol 2011, 40:885-901.
44. Bates M, O'Grady J, Mwaba P, et al. Evaluation of the burden of unsuspected pulmonary tuberculosis and co-morbidity with non-communicable diseases in sputum producing adult inpatients. PLoS One 2012, 7:e40774.
45. Pablos-Mendez A, Blustein J, Knirsch CA The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics. Am J Public Health 1997, 87:574-579.
46. Faurholt-Jepsen D, Range N, Praygod G, et al. The role of diabetes co-morbidity for tuberculosis treatment outcomes: a prospective cohort study from Mwanza, Tanzania. BMC Infect Dis 2012, 12:165.
47. Baker MA, Harries AD, Jeon CY, et al. The impact of diabetes on tuberculosis treatment outcomes. BMC Med 2011, 9:81.
48. Jiménez-Corona ME, Cruz-Hervert LP, García-García L, et al. Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes. Thorax 2012, published online Dec 18. 10.1136/thoraxjnl-2012-201756.
49. Collaborative framework for care and control of tuberculosis and diabetes International Union Against Tuberculosis and Lung Disease, WHOWHO, (accessed Jan 16, 2013). http://whqlibdoc.who.int/publications/2011/9789241502252_eng.pdf.
50. Colagiuri R, Brown J, Dain K Global diabetes plan 2011-2021 2011, International Diabetes Federation, Brussels.
51. De Wit S, Sabin CA, Weber R, et al. Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. Diabetes Care 2008, 31:1224-1229.
52. Justman JE, Benning L, Danoff A, et al. Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women. J Acquir Immune Defic Syndr 2003, 32:298-302.
53. Dye C, Bourdin Trunz B, Lönnroth K, Roglic G, Williams BG Nutrition, diabetes and tuberculosis in the epidemiological transition. PLoS One 2011, 6:e21161.
54. Cegielski P, McMurray DN The relationship between malnutrition and tuberculosis: evidence from studies in humans and experimental animals. Int J Tuberc Lung Dis 2004, 8:286-298.
55. Lönnroth K, Williams BG, Cegielski P, Dye C A consistent log-linear relationship between tuberculosis incidence and body mass index. Int J Epidemiol 2010, 39:149-155.
56. Cegielski JP, Arab L, Cornoni-Huntley J Nutritional risk factors for tuberculosis among adults in the United States, 1971-1992. Am J Epidemiol 2012, 176:409-422.
57. Lutter CK, Lutter R Fetal and early childhood undernutrition, mortality and lifelong health. Science 2012, 337:1495-1499.
58. Taylor-Robinson DC, Maayan N, Soares-Weiser K, Donegan S, Garner P Deworming drugs for soil-transmitted intestinal worms in children: effects on nutritional indicators, haemoglobin and school performance. Cochrane Database Syst Rev 2012, 7. CD000371.
59. Thomas TA, Mondal D, Noor Z, et al. Chronic helminth infections may negatively influence immunity against tuberculosis and other diseases of public health importance. Expert Rev Anti Infect Ther 2007, 5:475-484.
60. Woloshuk CP, Shim WB Aflatoxins, fumonisins, and trichothecenes: a convergence of knowledge. FEMS Microbiol Rev 2013, 37:94-109.
61. Bates MN, Khalakdina A, Pai M, et al. Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Arch Intern Med 2007, 167:335-342.
62. Hassmiller K The impact of smoking on population level tuberculosis outcomes: TSRU progress report 2007 2007, KNCV (Royal Netherlands Chemical Society), The Hague.
63. Brighenti S, Anderson J Local Immune responses in human tuberculosis: learning from the site of infection. J Infect Dis 2012, 205(suppl 2):S316-S324.
64. Ottenhoff THM The knowns and unknowns of the imunopathogenesis of tuberculosis. Int J Tuberc Lung Dis 2012, 16:1424-1432.
65. Lin H-H, Murray M, Cohen T, Colijn C, Ezzati M Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study. Lancet 2008, 372:1473-1483.
66. A WHO/The Union monograph on TB and tobacco control: joining efforts to control two related global epidemics WHO, International Union against Tuberculosis and Lung DiseaseInternational Union against Tuberculosis and Lung Disease, (accessed Jan 16, 2013). http://www.who.int/tobacco/resources/publications/tb_tob_control_monograph/en/index.html.
67. Lönnroth K, Williams BG, Stadlin S, Jaramillo E, Dye C Alcohol use as a risk factor for tuberculosis: a systematic review. BMC Public Health 2008, 8:289.
68. Rehm J, Samokhvalov AV, Popova S, et al. Alcohol consumption, alcohol use disorders and incidence and disease course of tuberculosis: is there a causal connection?. BMC Public Health 2009, 9:450.
69. Parry C, Ferreira-Borges C, Poznyak V, Lönnroth K, Rehm J The international study on alcohol and infectious diseases: three priorities for research. Addiction 2013, 108:1-2.
70. Sbrana E, Grise J, Stout C, Aronson J Co-morbidities associated with tuberculosis in an autopsy case series. Tuberculosis 2011, 91(suppl 1):S38-S42.
71. Pettit AC, Kaltenbach LA, Maruri F, et al. Chronic lung disease and HIV infection are risk factors for recurrent tuberculosis in a low-incidence setting. Int J Tuberc Lung Dis 2011, 15:906-911.
72. Cowie RL The epidemiology of tuberculosis in gold miners with silicosis. Am J Respir Crit Care Med 1994, 15:1460-1462.
73. van Zyl Smit RN, Pai M, Yew WW, et al. Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD. Eur Respir J 2010, 35:27-33.
74. Rabe KF, Ward B Uncovering and tackling Europe's hidden respiratory illness. Lancet 2012, 380:623-624.
75. Practical approach to lung health: manual on initiating PAL implementation WHO, (accessed Jan 16, 2013). http://whqlibdoc.who.int/hq/2008/WHO_HTM_TB_2008.410_eng.pdf.
76. Prevention European Respiratory Roadmap, (accessed Oct 13, 2012). http://www.ersroadmap.org/healthcare-professionals/prevention-chapter-1.html.
77. Nissapatorn V, Kuppusamy I, Josephine FP, et al. Tuberculosis: a resurgent disease in immunosuppressed patients. SE Asian J Trop Med Pub Health 2006, 37(suppl 3):S153-S160.
78. Ferrara G, Murray M, Winthrop K, et al. A: risk factors associated with pulmonary tuberculosis: smoking, diabetes and anti-TNFα drugs. Curr Opin Pulm Med 2012, 18:233-240.
79. Bosch W, Poowanawittayakom N, Chaikriangkrai K, et al. Tuberculous hepatitis in renal transplant recipients following alemtuzumab induction therapy. Transpl Infect Dis 2012, published online Dec 26. 10.1111/tid.12048.
80. Maejima H, Watarai A, Nakano T, Katayama C, Nishiyama H, Katsuoka K Adverse effects of methotrexate in three psoriatic arthritis patients. Rheumatol Int 2012, published online Dec 29. 10.1007/s00296-012-2649-0.
81. Glaziou P, Floyd K, Raviglione M Global burden and epidemiology of tuberculosis. Clin Chest Med 2009, 30:621-636.
82. Samaras V, Rafailidis PI, Mourtzoukou EG, Peppas G, Falagas ME Chronic bacterial and parasitic infections and cancer: a review. J Infect Dev Ctries 2010, 4:267-281.
83. Yu YH, Liao CC, Hsu WH, et al. Increased lung cancer risk among patients with pulmonary tuberculosis: a population cohort study. J Thorac Oncol 2011, 6:32-37.
84. Wu CY, Hu HY, Pu CY, et al. Aerodigestive tract, lung and haematological cancers are risk factors for tuberculosis: an 8-year population-based study. Int J Tuberc Lung Dis 2011, 15:125-130.
85. Vento S, Lanzafame M Tuberculosis and cancer: a complex and dangerous liaison. Lancet Oncol 2011, 12:520-522.
86. Kerkhof GF, Willemsen RH, Leunissen RW, Breukhoven PE, Hokken-Koelega AC Health profile of young adults born preterm: negative effects of rapid weight gain in early life. J Clin Endocrinol Metab 2012, 97:4498-4506.
87. Efferen LS Tuberculosis and pregnancy. Curr Opin Pulm Med 2007, 13:205-211.
88. Ahmed Y, Mwaba P, Chintu C, et al. A study of maternal mortality at the University Teaching Hospital, Lusaka, Zambia: the emergence of tuberculosis as a major non-obstetric cause of maternal death. Int J Tuberc Lung Dis 1999, 3:675-680.
89. Menendez C, Romagosa C, Ismail MR, et al. An autopsy study of maternal mortality in Mozambique: the contribution of infectious diseases. PLoS Med 2008, 5:e44.
90. Khan M, Pillay T, Moodley JM, Connolly CA Maternal mortality associated with tuberculosis-HIV-1 co-infection in Durban, South Africa. AIDS 2001, 15:1857-1863.
91. Cotton MF, Schaaf HS, Lottering G, et al. Tuberculosis exposure in HIV-exposed infants in a high-prevalence setting. Int J Tuberc Lung Dis 2008, 12:225-227.
92. Gupta A, Bhosale R, Kinikar A, et al. Maternal tuberculosis: a risk factor for mother-to-child transmission of human immunodeficiency virus. J Infect Dis 2011, 203:358-363.
93. Lin HC, Chen SF Increased risk of low birthweight and small for gestational age infants among women with tuberculosis. BJOG 2010, 117:585-590.
94. Hesseling AC, Cotton MF, Jennings T, et al. High incidence of tuberculosis among HIV-infected infants: evidence from a South African population-based study highlights the need for improved tuberculosis control strategies. Clin Infect Dis 2009, 48:108-114.
95. Cox JA, Lukande RL, Lucas S, Nelson AM, Van Marck E, Colebunders R Autopsy causes of death in HIV-positive individuals in sub-Saharan Africa and correlation with clinical diagnoses. AIDS Rev 2010, 12:183-194.
96. Broxmeyer L Diabetes mellitus, tuberculosis and the mycobacteria: two millenia of enigma. Med Hypotheses 2005, 65:433-439.
97. Orfila JJ Seroepidemiological evidence for an association between Chlamydia pneumoniae and atherosclerosis. Atherosclerosis 1998, 140(suppl 1):11-15.
98. Anestad G, Hoel T Atherosclerosis and tuberculosis: are they both chronic infectious diseases. Scand J Infect Dis 2001, 33:797.
99. Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the US Department of Health and Human Services. MMWR Recomm Rep 2012, 61(RR5):1-40. Centers for Disease Control and Prevention (CDC).
100. Sagnelli E, Starnini G, Sagnelli C, et al. Blood born viral infections, sexually transmitted diseases and latent tuberculosis in Italian prisons: a preliminary report of a large multicenter study. Eur Rev Med Pharmacol Sci 2012, 16:2142-2146.
101. Loveday M, Scott V, McLoughlin J, Amien F, Zweigenthal V Assessing care for patients with TB/HIV/STI infections in a rural district in KwaZulu-Natal. S Afr Med J 2011, 101:887-890.
102. Danquah I, Bedu-Addo G, Mockenhaupt FP Type 2 diabetes mellitus and increased risk for malaria infection. Emerg Infect Dis 2010, 16:1601-1604.
103. Rhodes SP, Otten JN, Hingorani GP, Hartley DP, Franklin RB Simultaneous assessment of cytochrome P450 activity in cultured human hepatocytes for compound-mediated induction of CYP3A4, CYP2B6, and CYP1A2. J Pharmacol Toxicol Methods 2011, 63:223-226.
104. Zumla A Mimics of sarcoidosis: leprosy. Sarcoidosis 1991, 8:89-94.
105. Oei W, Nishiura H The relationship between tuberculosis and influenza death during the influenza (H1N1) pandemic from 1918-19. Comput Math Methods Med 2012, 2012:124861.
106. Noh JY, Lee J, Choi WS, et al. Concurrent tuberculosis and influenza, South Korea. Emerg Infect Dis 2013, 19:165-167.
107. Moore DP, Klugman KP, Madhi SA Role of Streptococcus pneumoniae in hospitalization for acute community-acquired pneumonia associated with culture-confirmed Mycobacterium tuberculosis in children: a pneumococcal conjugate vaccine probe study. Pediatr Infect Dis J 2010, 29:1099-1104.
108. Raviglione M, Marais B, Floyd K, et al. Scaling up interventions to achieve global tuberculosis control: progress and new developments. Lancet 2012, 379:1902-1913.
109. Marais BJ, Raviglione M, Donald PR, et al. Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action. Lancet 2010, 375:2179-2191.
110. Samb B, Desai N, Nishtar S, et al. Prevention and management of chronic disease: a litmus test for health-systems strengthening in low-income and middle-income countries. Lancet 2010, 376:1785-1797.
111. Rasanathan K, Sivasankara Kurup A, Jaramillo E, Lönnroth K The social determinants of health: key to global tuberculosis control. Int J Tuberc Lung Dis 2011, 15(suppl 2):S30-S36.
112. Ploubidis GB, Palmer MJ, Blackmore C, et al. Social determinants of tuberculosis in Europe: a prospective ecological study. Eur Respir J 2012, 40:925-930.
113. Lönnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med 2009, 68:2240-2246.
114. Farmer P Social scientists and the new tuberculosis. Soc Sci Med 1997, 44:347-358.
115. Marmot M Fair society, healthy lives: the Marmot review-strategic review of health inequalities in England post-2010 (accessed Feb 5, 2013). http://www.instituteofhealthequity.org/Content/FileManager/pdf/fairsocietyhealthylives.pdf.
116. Closing the gap in a generation: health equity through action on the social determinants of health-final report of the Commission on Social Determinants of Health 2008, CSDH, World Health Organization, Geneva.
117. Life expectancy at birth, total (years): 2008-2012. January, 2013 The World Bank, (accessed Jan 4, 2013). http://data.worldbank.org/indicator/SP.DYN.LE00.IN.
118. Marmot M, Allen J, Bell R, Bloomer E, Goldblatt P WHO European review of social determinants of health and the health divide. Lancet 2012, 380:1011-1029. on behalf of the Consortium for the European Review of Social Determinants of Health and the Health Divide.
119. Tudor Hart J The inverse care law. Lancet 1971, 297:405-412.
120. Briggs CJ, Garner P Strategies for integrating primary health services in middle- and low-income countries at the point of delivery. Cochrane Database Syst Rev 2006, 2. CD003318.
121. Integrated health services: what and why? WHO, (accessed Jan 17, 2013). http://www.who.int/healthsystems/technical_brief_final.pdf.
122. Gounder CR, Chaisson RE A diagonal approach to building primary healthcare systems in resource-limited settings: women-centred integration of HIV/AIDS, tuberculosis, malaria, MCH and NCD initiatives. Trop Med Int Health 2012, 17:1426-1431.
123. Craig GM, Booth H, Hall J, et al. Establishing a new service role in tuberculosis care: the tuberculosis link worker. J Adv Nurs 2008, 61:413-424.
124. Jit M, Stagg HR, Aldridge RW, White PJ, Abubakar I Dedicated outreach service for hard to reach patients with tuberculosis in London: observational study and economic evaluation. BMJ 2011, 343:d5376.
125. Kimbrough W, Saliba V, Dahab M, Haskew C, Checchi F The burden of tuberculosis in crisis-affected populations: a systematic review. Lancet Infect Dis 2012, 12:950-965.
126. Hargreaves JR, Boccia D, Evans CA, Adato M, Petticrew M, Porter JD The social determinants of tuberculosis: from evidence to action. Am J Public Health 2011, 101:654-662.
127. Creswell J, Raviglione M, Ottmani S, et al. Tuberculosis and noncommunicable diseases: neglected links and missed opportunities. Eur Respir J 2011, 37:1269-1282.
128. Khan AJ, Khowaja S, Khan FS, et al. Engaging the private sector to increase tuberculosis case detection: an impact evaluation study. Lancet Infect Dis 2012, 12:608-616.